Ascletis Pharma Inc
HKEX:1672

Watchlist Manager
Ascletis Pharma Inc Logo
Ascletis Pharma Inc
HKEX:1672
Watchlist
Price: 1.51 HKD -4.43% Market Closed
Market Cap: 1.5B HKD
Have any thoughts about
Ascletis Pharma Inc?
Write Note

Ascletis Pharma Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ascletis Pharma Inc
Cash from Financing Activities Peer Comparison

Comparables:
6160
603392
002252
300122
300896

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Ascletis Pharma Inc
HKEX:1672
Cash from Financing Activities
-ÂĄ81.5m
CAGR 3-Years
-56%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Cash from Financing Activities
ÂĄ2.6B
CAGR 3-Years
-57%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Cash from Financing Activities
-ÂĄ893.3m
CAGR 3-Years
N/A
CAGR 5-Years
-98%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Cash from Financing Activities
-ÂĄ1.2B
CAGR 3-Years
-25%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Cash from Financing Activities
-ÂĄ3.5B
CAGR 3-Years
-1%
CAGR 5-Years
-52%
CAGR 10-Years
-47%
Imeik Technology Development Co Ltd
SZSE:300896
Cash from Financing Activities
-ÂĄ1.4B
CAGR 3-Years
N/A
CAGR 5-Years
-98%
CAGR 10-Years
N/A

See Also

What is Ascletis Pharma Inc's Cash from Financing Activities?
Cash from Financing Activities
-81.5m CNY

Based on the financial report for Dec 31, 2023, Ascletis Pharma Inc's Cash from Financing Activities amounts to -81.5m CNY.

What is Ascletis Pharma Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-56%

Over the last year, the Cash from Financing Activities growth was -5 643%. The average annual Cash from Financing Activities growth rates for Ascletis Pharma Inc have been -56% over the past three years .

Back to Top